ACLX
Price
$62.44
Change
-$4.79 (-7.12%)
Updated
Apr 3 closing price
Capitalization
3.43B
34 days until earnings call
LENZ
Price
$23.02
Change
-$2.49 (-9.76%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
633.21M
Ad is loading...

ACLX vs LENZ

Header iconACLX vs LENZ Comparison
Open Charts ACLX vs LENZBanner chart's image
Arcellx
Price$62.44
Change-$4.79 (-7.12%)
Volume$645.74K
Capitalization3.43B
LENZ Therapeutics
Price$23.02
Change-$2.49 (-9.76%)
Volume$4.65K
Capitalization633.21M
ACLX vs LENZ Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. LENZ commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and LENZ is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ACLX: $62.44 vs. LENZ: $22.99)
Brand notoriety: ACLX and LENZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 104% vs. LENZ: 117%
Market capitalization -- ACLX: $3.43B vs. LENZ: $633.21M
ACLX [@Biotechnology] is valued at $3.43B. LENZ’s [@Biotechnology] market capitalization is $633.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileLENZ’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • LENZ’s FA Score: 0 green, 5 red.
According to our system of comparison, LENZ is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 6 TA indicator(s) are bullish while LENZ’s TA Score has 6 bullish TA indicator(s).

  • ACLX’s TA Score: 6 bullish, 4 bearish.
  • LENZ’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than LENZ.

Price Growth

ACLX (@Biotechnology) experienced а -8.86% price change this week, while LENZ (@Biotechnology) price change was -13.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

ACLX is expected to report earnings on May 08, 2025.

LENZ is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($3.43B) has a higher market cap than LENZ($633M). ACLX YTD gains are higher at: -18.581 vs. LENZ (-20.367). ACLX has more cash in the bank: 587M vs. LENZ (217M). LENZ has less debt than ACLX: LENZ (1.58M) vs ACLX (54.1M).
ACLXLENZACLX / LENZ
Capitalization3.43B633M542%
EBITDA-99.06MN/A-
Gain YTD-18.581-20.36791%
P/E RatioN/AN/A-
Revenue108MN/A-
Total Cash587M217M271%
Total Debt54.1M1.58M3,428%
TECHNICAL ANALYSIS
Technical Analysis
ACLXLENZ
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 15 days ago
87%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
STFGX113.79N/A
N/A
State Farm Growth
FMPOX27.43N/A
N/A
Fidelity Advisor Mid Cap Value I
LKBLX52.81N/A
N/A
LK Balanced Institutional
ADOZX20.81N/A
N/A
Alger Dynamic Opportunities Z
MXEBX14.99N/A
N/A
Empower Core Strategies US Eq Instl

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with RCKT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
-7.12%
RCKT - ACLX
54%
Loosely correlated
-11.75%
DNLI - ACLX
53%
Loosely correlated
-6.91%
KRYS - ACLX
51%
Loosely correlated
-1.59%
RNA - ACLX
49%
Loosely correlated
-5.61%
KYMR - ACLX
49%
Loosely correlated
-10.13%
More

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with KYMR. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
-9.88%
KYMR - LENZ
38%
Loosely correlated
-10.13%
ERAS - LENZ
38%
Loosely correlated
-3.97%
KALV - LENZ
37%
Loosely correlated
+2.07%
ACLX - LENZ
37%
Loosely correlated
-7.12%
TRDA - LENZ
37%
Loosely correlated
-9.09%
More